Ionis Pharmaceuticals IONS Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's interest income?
- Ionis Pharmaceuticals (IONS) reported interest income of $25.48M in Q1 2026.
- How has Ionis Pharmaceuticals's interest income changed year-over-year?
- Ionis Pharmaceuticals's interest income increased by 3.3% year-over-year, from $24.67M to $25.48M.
- What is the long-term trend for Ionis Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's interest income has grown at a 76.6% compound annual growth rate (CAGR), from $10.06M to $97.77M.
- What does interest income mean?
- Earnings from cash and investment holdings.
- How do you interpret interest income?
- Higher interest income suggests a strong cash position and effective treasury management.
- How does interest income compare across companies?
- Highly dependent on the company's cash balance and the prevailing interest rate environment.